Gyounghyun Bae

Array ( [id] => 20390991 [patent_doc_number] => 20250366466 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2025-12-04 [patent_title] => SYSTEMS AND METHODS FOR REVERSIBLE CRYOPRESERVATION [patent_app_type] => utility [patent_app_number] => 19/228566 [patent_app_country] => US [patent_app_date] => 2025-06-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 65932 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -18 [patent_words_short_claim] => 114 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 19228566 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 20100512 [patent_doc_number] => 20250230448 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2025-07-17 [patent_title] => INTEGRATIVE PLASMID [patent_app_type] => utility [patent_app_number] => 19/042240 [patent_app_country] => US [patent_app_date] => 2025-01-31 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 28581 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -29 [patent_words_short_claim] => 81 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 19042240 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 20032049 [patent_doc_number] => 20250170271 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2025-05-29 [patent_title] => COMPOSITIONS AND METHODS FOR THERAPEUTIC DELIVERY [patent_app_type] => utility [patent_app_number] => 18/948331 [patent_app_country] => US [patent_app_date] => 2024-11-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 30481 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -19 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18948331 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 20343136 [patent_doc_number] => 12466858 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2025-11-11 [patent_title] => Helper plasmid and method for preparing recombinant adeno-associated virus [patent_app_type] => utility [patent_app_number] => 18/377827 [patent_app_country] => US [patent_app_date] => 2023-10-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 0 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 111 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18377827 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 19113094 [patent_doc_number] => 20240124844 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2024-04-18 [patent_title] => METHOD FOR PREPARING COMPOSITION COMPRISING MESENCHYMAL STEM CELL, EXTRACELLULAR VESICLE PRODUCED BY MESENCHYMAL STEM CELL, AND GROWTH FACTOR, COMPOSITION PREPARED BY THE METHOD, AND USE OF COMPOSITION FOR TREATING ARTHRITIS [patent_app_type] => utility [patent_app_number] => 18/376459 [patent_app_country] => US [patent_app_date] => 2023-10-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 8232 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -19 [patent_words_short_claim] => 95 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18376459 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 19281849 [patent_doc_number] => 20240218323 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2024-07-04 [patent_title] => PLATELETS-CONTAINING COMPOSITION AND PREPARATION PROCESS THEREOF [patent_app_type] => utility [patent_app_number] => 18/235597 [patent_app_country] => US [patent_app_date] => 2023-08-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 4895 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -15 [patent_words_short_claim] => 59 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18235597 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 18953610 [patent_doc_number] => 20240041937 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2024-02-08 [patent_title] => PROPHYLAXIS AND TREATMENT OF ORTHOPOX VIRUSES USING REGENERATIVE CELLS AND PRODUCTS THEREOF [patent_app_type] => utility [patent_app_number] => 18/366527 [patent_app_country] => US [patent_app_date] => 2023-08-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 10136 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -17 [patent_words_short_claim] => 20 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18366527 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 19496572 [patent_doc_number] => 20240335590 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2024-10-10 [patent_title] => METHOD FOR MANUFACTURING EXTRACELLULAR MATRIX COMPOSITION [patent_app_type] => utility [patent_app_number] => 18/225482 [patent_app_country] => US [patent_app_date] => 2023-07-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 4785 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -9 [patent_words_short_claim] => 124 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18225482 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 18466988 [patent_doc_number] => 20230201268 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2023-06-29 [patent_title] => TREATMENT OF CANCER BY ADMINISTRATION OF NEURONS AND DERIVATIVES THEREOF [patent_app_type] => utility [patent_app_number] => 18/083043 [patent_app_country] => US [patent_app_date] => 2022-12-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 39567 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -19 [patent_words_short_claim] => 36 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18083043 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 18649826 [patent_doc_number] => 20230295651 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2023-09-21 [patent_title] => RECOMBINANT NUCLEIC ACID CONSTRUCT AND USE THEREOF [patent_app_type] => utility [patent_app_number] => 17/885088 [patent_app_country] => US [patent_app_date] => 2022-08-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 47659 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -19 [patent_words_short_claim] => 583 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17885088 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 18005306 [patent_doc_number] => 20220364072 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2022-11-17 [patent_title] => FUSION PROTEIN THAT IMPROVES GENE EDITING EFFICIENCY AND APPLICATION THEREOF [patent_app_type] => utility [patent_app_number] => 17/843462 [patent_app_country] => US [patent_app_date] => 2022-06-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 9977 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -49 [patent_words_short_claim] => 22 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17843462 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 19556753 [patent_doc_number] => 20240368545 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2024-11-07 [patent_title] => MANUFACTURING METHOD OF MEMORY T CELLS [patent_app_type] => utility [patent_app_number] => 18/289361 [patent_app_country] => US [patent_app_date] => 2022-05-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 16164 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -11 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18289361 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 17911350 [patent_doc_number] => 20220313745 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2022-10-06 [patent_title] => WOUND TREATMENTS AND METHODS OF STABILIZING, PROTECTING, AND TREATING A WOUND [patent_app_type] => utility [patent_app_number] => 17/704539 [patent_app_country] => US [patent_app_date] => 2022-03-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 27538 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -20 [patent_words_short_claim] => 64 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17704539 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 18056581 [patent_doc_number] => 20220387667 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2022-12-08 [patent_title] => METHODS OF PRODUCING DECELLULARIZED AND RECELLULARIZED PROSTATE TISSUES AND TREATING BENIGN PROSTATIC HYPERPLASIA OR PROSTATE CANCER [patent_app_type] => utility [patent_app_number] => 17/703316 [patent_app_country] => US [patent_app_date] => 2022-03-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 11741 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -18 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17703316 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 17865217 [patent_doc_number] => 20220287952 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2022-09-15 [patent_title] => COMPOSITIONS CONTAINING EXOSOMES FROM ANIMAL PLACENTA, METHODS FOR PRODUCING THE SAME AND USES THEREOF [patent_app_type] => utility [patent_app_number] => 17/694715 [patent_app_country] => US [patent_app_date] => 2022-03-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 9443 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -19 [patent_words_short_claim] => 62 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17694715 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 18565738 [patent_doc_number] => 20230256065 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2023-08-17 [patent_title] => AUTOLOGOUS STEM CELL VACCINE AND METHODS [patent_app_type] => utility [patent_app_number] => 17/673107 [patent_app_country] => US [patent_app_date] => 2022-02-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 4365 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -32 [patent_words_short_claim] => 50 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17673107 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 19049442 [patent_doc_number] => 20240091411 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2024-03-21 [patent_title] => EAR CARTILAGE TISSUE ENGINEERING COMPLEX AND USE THEREOF [patent_app_type] => utility [patent_app_number] => 18/262224 [patent_app_country] => US [patent_app_date] => 2022-01-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 7786 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -17 [patent_words_short_claim] => 39 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18262224 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 20465421 [patent_doc_number] => 12521450 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2026-01-13 [patent_title] => DNA, expression vector, transcript, cell, pharmaceutical composition, and medicine [patent_app_type] => utility [patent_app_number] => 17/576827 [patent_app_country] => US [patent_app_date] => 2022-01-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 8 [patent_no_of_words] => 0 [patent_no_of_claims] => 13 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 123 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17576827 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 19020547 [patent_doc_number] => 20240076718 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2024-03-07 [patent_title] => CRISPNA FOR GENOME EDITING [patent_app_type] => utility [patent_app_number] => 18/260017 [patent_app_country] => US [patent_app_date] => 2021-12-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 9211 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -10 [patent_words_short_claim] => 87 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18260017 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 20437484 [patent_doc_number] => 12508305 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2025-12-30 [patent_title] => Compositions and methods for treating and/or preventing glycogen storage disease type III [patent_app_type] => utility [patent_app_number] => 17/560595 [patent_app_country] => US [patent_app_date] => 2021-12-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 16 [patent_figures_cnt] => 48 [patent_no_of_words] => 26697 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 63 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17560595 [rel_patent_id] =>[rel_patent_doc_number] =>)